Founded in 2014 by Dr. Sara Naseri and Søren Therkelsen, Qvin aims to revolutionize women's healthcare by utilizing menstrual blood for critical health diagnostics. Their core mission is to empower women by providing an alternative to traditional lab tests, enabling them to access personalized health data from the comfort of their homes. Qvin's innovative service transforms menstrual blood into lab reports, offering a needle-free, convenient method for women to monitor their health.
Qvin has garnered attention for its groundbreaking approach, attracting notable investors and healthcare professionals. The company has achieved significant milestones, including patenting its unique technology and gaining recognition in the healthcare industry. By providing an accessible and non-invasive diagnostic tool, Qvin has made a substantial impact on women's health, challenging the status quo and advocating for greater autonomy and prioritization of women's healthcare needs.
